RedHill Biopharma Ltd – (NASDAQ:RDHL)’s share price rose 13.8% during mid-day trading on Monday . The stock traded as high as $14.95 and last traded at $14.94, with a volume of 158,449 shares. The stock had previously closed at $13.13.

RDHL has been the topic of several research reports. FBR & Co reissued a “buy” rating on shares of RedHill Biopharma Ltd – in a research note on Wednesday, April 13th. Zacks Investment Research lowered RedHill Biopharma Ltd – from a “hold” rating to a “sell” rating in a research report on Friday, July 29th. Two equities research analysts have rated the stock with a sell rating and six have issued a buy rating to the stock. RedHill Biopharma Ltd – currently has an average rating of “Buy” and an average price target of $26.00.

The company’s 50-day moving average price is $11.43 and its 200-day moving average price is $11.16. The firm’s market cap is $187.57 million.

RedHill Biopharma Ltd – (NASDAQ:RDHL) last announced its quarterly earnings data on Wednesday, July 27th. The company reported ($0.06) EPS for the quarter, beating the Zacks’ consensus estimate of ($0.58) by $0.52. Analysts forecast that RedHill Biopharma Ltd – will post ($1.97) earnings per share for the current year.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.